Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $117,819 | 65 | 75.5% |
| Food and Beverage | $17,773 | 504 | 11.4% |
| Travel and Lodging | $11,345 | 40 | 7.3% |
| Consulting Fee | $8,900 | 4 | 5.7% |
| Education | $130.99 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $134,275 | 262 | $0 (2024) |
| Allergan, Inc. | $9,920 | 61 | $0 (2022) |
| Bayer HealthCare Pharmaceuticals Inc. | $2,845 | 11 | $0 (2018) |
| ABBVIE INC. | $2,448 | 66 | $0 (2024) |
| PFIZER INC. | $829.15 | 39 | $0 (2023) |
| LEO Pharma Inc. | $796.17 | 54 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $505.63 | 13 | $0 (2019) |
| MERZ NORTH AMERICA, INC. | $500.54 | 5 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $457.01 | 9 | $0 (2017) |
| GENZYME CORPORATION | $419.95 | 12 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,320 | 29 | ABBVIE INC. ($746.02) |
| 2023 | $29,301 | 48 | Galderma Laboratories, L.P. ($28,510) |
| 2022 | $23,317 | 73 | Galderma Laboratories, L.P. ($22,375) |
| 2021 | $4,973 | 52 | Galderma Laboratories, L.P. ($3,731) |
| 2020 | $14,003 | 67 | Galderma Laboratories, L.P. ($13,136) |
| 2019 | $20,207 | 78 | Galderma Laboratories, L.P. ($18,834) |
| 2018 | $28,809 | 125 | Galderma Laboratories, L.P. ($27,158) |
| 2017 | $34,037 | 145 | Galderma Laboratories, L.P. ($20,264) |
All Payment Transactions
617 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $31.13 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $141.75 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/27/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $181.58 | General |
| 10/25/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $40.02 | General |
| Category: ACNE | ||||||
| 09/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/19/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $27.60 | General |
| 09/19/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $27.60 | General |
| 09/04/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $20.98 | General |
| 08/15/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $32.50 | General |
| 08/15/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $32.50 | General |
| 08/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/07/2024 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $44.62 | General |
| Category: Dermatology | ||||||
| 07/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/16/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $29.55 | General |
| 07/16/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $29.55 | General |
| 06/18/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $101.44 | General |
| 06/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: FACIAL AESTHETICS | ||||||
| 06/07/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 05/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $136.51 | General |
| Category: FACIAL AESTHETICS | ||||||
| 05/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 05/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/20/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 11 | 12 | $2,323 | $626.19 |
| 2022 | 6 | 116 | 177 | $27,513 | $8,105 |
| 2021 | 5 | 73 | 193 | $21,399 | $6,854 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 12 | $2,323 | $626.19 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 41 | $8,855 | $2,577 | 29.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 25 | 28 | $7,415 | $2,075 | 28.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 19 | 25 | $4,205 | $1,097 | 26.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $3,174 | $1,091 | 34.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 18 | 22 | $2,998 | $968.22 | 32.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 13 | 49 | $867.30 | $297.65 | 34.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 30 | $6,529 | $2,042 | 31.3% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 12 | 15 | $4,400 | $1,525 | 34.7% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 15 | 18 | $4,831 | $1,514 | 31.3% |
| 17000 | Destruction of skin growth | Office | 2021 | 15 | 23 | $3,815 | $1,162 | 30.4% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 12 | 107 | $1,824 | $611.03 | 33.5% |
About Dr. William Kwan, MD
Dr. William Kwan, MD is a Dermatology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376504407.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Kwan, MD has received a total of $155,967 in payments from pharmaceutical and medical device companies, with $1,320 received in 2024. These payments were reported across 617 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($117,819).
As a Medicare-enrolled provider, Kwan has provided services to 200 Medicare beneficiaries, totaling 382 services with total Medicare billing of $15,585. Data is available for 3 years (2021–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Los Angeles, CA
- Active Since 03/29/2006
- Last Updated 07/09/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1376504407
Products in Payments
- AKLIEF (Drug) $52,294
- EPIDUO FORTE (Drug) $37,106
- ORACEA (Drug) $18,516
- SOOLANTRA (Drug) $11,278
- TWYNEO (Drug) $8,051
- ACZONE (Drug) $4,192
- MIRVASO (Drug) $3,876
- Finacea (Drug) $2,845
- EPSOLAY (Drug) $1,943
- BOTOX (Biological) $704.38
- EUCRISA (Drug) $699.14
- COSENTYX (Biological) $505.63
- SKYRIZI (Biological) $463.06
- ADBRY (Biological) $355.37
- ENSTILAR (Drug) $333.96
- REMICADE (Biological) $318.45
- HUMIRA (Biological) $301.28
- Humira (Biological) $245.30
- DAXXIFY (Drug) $236.55
- BOTOX COSMETIC (Biological) $229.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Los Angeles
Christopher Ho, Md, MD
Dermatology — Payments: $929,207
Dr. Howard Sofen, M.d, M.D
Dermatology — Payments: $654,301
Jennifer Hsiao, M.d, M.D
Dermatology — Payments: $400,325
Dr. Pearl Grimes, Md, MD
Dermatology — Payments: $358,500
Derek Jones, Md, MD
Dermatology — Payments: $316,086
Rebecca Fitzgerald, M.d, M.D
Dermatology — Payments: $281,818